Skip to main content
logo
Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
4.590
+0.330 (7.75%)
At close: Aug 27, 2025, 4:00 PM
4.500
-0.090 (-1.96%)
Pre-market: Aug 28, 2025, 4:29 AM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Exemplar
6.15M
Log In
Log In
Log In
Log In
Upgrade
Exemplar Growth
-48.81%
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceuticals
75.00K
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceuticals Growth
-99.50%
Log In
Log In
Log In
Log In
Upgrade
Trans Ova
-
Log In
Log In
Log In
Log In
Upgrade
Trans Ova Growth
-
Log In
Log In
Log In
Log In
Upgrade
Human Biotherapeutics
-
Log In
Log In
Log In
Log In
Upgrade
All Other
-
Log In
Log In
Log In
Log In
Upgrade
All Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
ActoBio
-
Log In
Log In
Log In
Log In
Upgrade
ActoBio Growth
-
Log In
Log In
Log In
Log In
Upgrade
PGEN Therapeutics, Inc.
-
Log In
Log In
Log In
Log In
Upgrade
PGEN Therapeutics, Inc. Growth
-
Log In
Log In
Log In
Log In
Upgrade
MBP Titan
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
6.23M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-76.66%
Log In
Log In
Log In
Log In
Upgrade
Foreign
-
Log In
Log In
Log In
Log In
Upgrade
Foreign Growth
-
Log In
Log In
Log In
Log In
Upgrade